ARCA biopharma, Inc. Business Operations Contracts & Agreements
35 Contracts & Agreements
- Agency Agreements (5 contracts)
- Collaboration Agreements (12)
- Cooperation Agreements (1)
- Development Agreements (4)
- Indemnification Agreements (1)
- Sales Agreements (10)
- Voting Agreements (2)
- Form of Indemnification Agreement between Oruka Therapeutics, Inc. and its directors and officers (Filed With SEC on May 14, 2024)
- Cooperation Agreement, dated as of June 15, 2022, by and among ARCA biopharma, Inc., Cable Car Capital LLC, the Funicular Fund LP, Funicular Funds, LP and Jacob Ma-Weaver (Filed With SEC on June 21, 2022)
- Amendment No. 1 to Capital on DemandTM Sales Agreement, dated April 6, 2021, by and between ARCA biopharma, Inc. and JonesTrading Institutional Services LLC (Filed With SEC on April 6, 2021)
- Capital on DemandTM Sales Agreement, dated July 22, 2020, by and between ARCA biopharma, Inc. and JonesTrading Institutional Services LLC (Filed With SEC on July 22, 2020)
- Amendment No. 8 to Capital on DemandTM Sales Agreement, dated July 14, 2020, by and between ARCA biopharma, Inc. and JonesTrading Institutional Services LLC (Filed With SEC on July 14, 2020)
- Amendment No. 7 to Capital on DemandTM Sales Agreement, dated July 2, 2020, by and between ARCA biopharma, Inc. and JonesTrading Institutional Services LLC (Filed With SEC on July 2, 2020)
- Amendment No. 6 to Capital on DemandTM Sales Agreement, dated June 28, 2019, by and between ARCA biopharma, Inc. and JonesTrading Institutional Services LLC (Filed With SEC on June 28, 2019)
- Amendment No. 5 to Capital on DemandTM Sales Agreement, dated May 20, 2019, by and between ARCA biopharma, Inc. and JonesTrading Institutional Services LLC (Filed With SEC on May 20, 2019)
- Amendment No. 4 to Capital on DemandTM Sales Agreement, dated May 9, 2019, by and between ARCA biopharma, Inc. and JonesTrading Institutional Services LLC (Filed With SEC on May 9, 2019)
- Amendment No. 3 to Capital on DemandTM Sales Agreement, dated March 11, 2019, by and between ARCA biopharma, Inc. and JonesTrading Institutional Services LLC (Filed With SEC on March 11, 2019)
- Amendment No. 2 to Capital on DemandTM Sales Agreement, dated January 25, 2019, by and between ARCA biopharma, Inc. and JonesTrading Institutional Services LLC (Filed With SEC on January 25, 2019)
- AMENDMENT NO. 1 TO CAPITAL ON DEMAND SALES AGREEMENT (Filed With SEC on August 21, 2017)
- EUROPEAN ADDENDUM TO THE CLINICAL TRIAL COLLABORATION AGREEMENT BETWEEN MEDTRONIC AND ARCA (Filed With SEC on March 21, 2017)
- CANADIAN ADDENDUM TO THE CLINICAL TRIAL COLLABORATION AGREEMENT BETWEEN MEDTRONIC AND ARCA (Filed With SEC on March 19, 2015)
- SECOND AMENDMENT TO CLINICAL TRIAL COLLABORATION AGREEMENT (Filed With SEC on November 12, 2014)
- FIRST AMENDMENT TO CLINICAL TRIAL COLLABORATION AGREEMENT (Filed With SEC on August 13, 2014)
- Amendment No. 1 to Placement Agency Agreement dated January 21, 2014 (Filed With SEC on February 4, 2014)
- PLACEMENT AGENCY AGREEMENT January 21, 2014 (Filed With SEC on February 4, 2014)
- CLINICAL TRIAL COLLABORATION AGREEMENT (Filed With SEC on April 22, 2013)
- PLACEMENT AGENCY AGREEMENT (Filed With SEC on February 1, 2013)
- PLACEMENT AGENCY AGREEMENT (Filed With SEC on August 3, 2012)
- PLACEMENT AGENCY AGREEMENT April 18, 2011 (Filed With SEC on April 18, 2011)
- SECOND AMENDED AND RESTATED COLLABORATION AND LICENSE AGREEMENT (Filed With SEC on August 10, 2010)
- AMENDMENT NO. 2 TO DEVELOPMENT, COMMERCIALIZATION AND LICENSING AGREEMENT (Filed With SEC on May 15, 2009)
- AMENDMENT NO. 1 TO DEVELOPMENT, COMMERCIALIZATION AND LICENSING AGREEMENT (Filed With SEC on May 15, 2009)
- DEVELOPMENT, COMMERCIALIZATION AND LICENSING AGREEMENT BETWEEN (Filed With SEC on May 15, 2009)
- FIRST AMENDMENT TO DIAGNOSTIC COLLABORATION AND OPTION AGREEMENT (Filed With SEC on May 15, 2009)
- DIAGNOSTIC COLLABORATION AND OPTION AGREEMENT (Filed With SEC on May 15, 2009)
- VOTING AGREEMENT (Filed With SEC on October 30, 2008)
- VOTING AGREEMENT (Filed With SEC on October 30, 2008)
- AMENDED AND RESTATED COLLABORATION AND LICENSE AGREEMENT (Filed With SEC on November 8, 2006)
- Drug Product Development and Clinical Supply Agreement (Filed With SEC on August 8, 2006)
- LICENSE AND COLLABORATION AGREEMENT BY AND BETWEEN (Filed With SEC on March 15, 2006)
- COLLABORATION AGREEMENT (Filed With SEC on May 10, 2005)
- COLLABORATION AGREEMENT (Filed With SEC on February 19, 2004)
